National Holdings Board of Directors
Michael S. Weiss was elected as Chairman of the Board of National Holdings Corporation on September 21, 2016. Mr. Weiss has served as Fortress Biotech's Executive Vice Chairman, Strategic Development since January 2014 and has served as co-vice chairman of Fortress Biotech's board of directors since December 2013. Since 2009, Mr. Weiss has served as Co-Portfolio Manager and Partner of Opus. In 2011, Mr. Weiss co-founded TG Therapeutics, Inc. (NASDAQ: TGTX), a publicly-traded biotechnology company focused on acquiring, developing and commercializing drugs for the treatment of b-cell malignancies. Mr. Weiss currently serves as TG’s Executive Chairman, Interim CEO and President. Prior to 2009, Mr. Weiss was Chairman and CEO of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) where he helped the company acquire and develop its lead drug Zerenex as well as executed a $100MM+ strategic alliance for Zerenex with JT Tobacco, Inc. and Torii Pharmaceutical Co., Ltd. Mr. Weiss began his professional career as a lawyer with Cravath, Swaine & Moore LLP in NYC. Mr. Weiss earned his J.D. from Columbia Law School and his B.S. in Finance from The University at Albany.
Robert Fagenson has been a member of National’s Board since March 2012. He served as Executive Co-Chairman from July 2012 to December 2014 and as Chairman from January 2014 to September 2016. Mr. Fagenson is currently the Vice Chairman of the Board, President and Chief Executive Officer of National Holdings Corporation.
Mr. Fagenson spent the majority of his career at the New York Stock Exchange, where he was Managing Partner of one of largest specialist firms operating on the exchange trading floor. During his career as a member of the New York Stock Exchange beginning in 1973, Mr. Fagenson served as a Governor on the trading floor and was elected to the NYSE Board of Directors in 1993, where he served for six years, eventually becoming Vice Chairman of the Board in 1998 to 1999. He returned to the Board in 2003 and served until the Board was reconstituted with only non-industry directors in 2004.
Mr. Fagenson has been CEO of Fagenson & Co, Inc, a 50 year old broker dealer that engaged in institutional brokerage as well as investment banking and money management. On March 1, 2012, Fagenson transferred its brokerage operation, accounts and personnel to National Securities Corporation, and operates as a branch office of that firm.
Mr. Fagenson has served on the boards of a number of public companies and presently is the Non-Executive Chairman of Document Security Systems, Inc. (NYSEMKT: DSS) and a member of the Board of Cash Technologies Corp. He is also a Director of the National Organization of Investment Professionals (NOIP). In addition to his business related activities, Mr. Fagenson, serves as Vice President and a Director of New York Services for the Handicapped, Treasurer and Director of the Centurion Foundation, Director of the Federal Law Enforcement Officers Association Foundation, Treasurer and Director of the New York City Police Museum and as a Member of the Board of the Sports and Arts in Schools Foundation. He is a Member of the alumni boards of both the Whitman School of Business and the Athletic Department at Syracuse University.. Mr. Fagenson received his B.S. degree in Transportation Sciences & Finance from Syracuse University in 1970.
Daniel Hume is currently a partner in Kirby McInerney, LLP's New York office and is a member of the firm's management committee. Mr. Hume's law practice focuses on securities, structured finance, and antitrust litigation and regulation. He joined Kirby McInerney, LLP in 1995. Since then, Mr. Hume has advised corporate, public, and individual clients, including some of the largest institutional investors in the world, and helped them recover billions of dollars in losses throughout the course of his career. His work has earned him assorted honors and recognition, including most recently being named to both the National Law Journal’s "hot" list and Law360’s "most feared" list for 2013. Mr. Hume is admitted to the New York State Bar and federal courts around the country, including the United States District Courts for the Southern and Eastern Districts of New York, the United States Court of Appeals for the Second, Third, Fourth, and Fifth Circuits, the Appellate Division of the Supreme Court of the State of New York, First Judicial Department, and the United States Supreme Court. He graduated from the State University of New York at Albany magna cum laude (B.A. Philosophy, 1988) and from Columbia Law School, where he served as Notes Editor for the Columbia Journal of Environmental Law (J.D., 1991).
Mr. Hume serves on the Board of Directors of TG Therapeutics Inc.
Neil Herskowitz has been the President at Riverside Claims LLC. since June 2004. Mr. Herskowitz has been the President of Riverside Contracting LLC since June 1998. He has been a Managing Member of ReGen Partners LLC since 1998 which includes ReGen Capital Investments LLC and Riverside Claims Investments LLC. Mr. Herskowitz serves as a Managing Member of Riverside Contracting LLC. In addition, he serves as Chairman of the Board of Directors of Starting Point Services for Children. Mr. Herskowitz also serves on the Board of Directors of Checkpoint Therapeutics, Inc. and Avenue Therapeutics, Inc. which are both affiliated companies of Fortress Biotech Inc. (FBIO). Previously, Mr. Herskowitz served on numerous boards of publicly traded companies including CB Pharma Acquisition Corp., CytRx Oncology Corporation, Alacrity Biosciences, Innovive Pharmaceuticals, TG Therapeutics, Inc. (formerly Manhattan Pharmaceuticals Inc.), and Chelsea Therapeutics International Ltd. (formerly Ivory Capital Corp.) Mr. Herskowitz holds a B.B.A. in Finance from Bernard M. Baruch College in 1978.
Eli Salig was President and Chief Operating Officer of ASI Solutions, Inc. (ASIS), a human resources consulting and outsourcing firm he co-founded in 1978. With prestigious clients such as Hewlett-Packard, Verizon and Morgan Stanley, and key acquisitions, ASIS grew to a major factor in the industry with over 1,600 employees world-wide and in excess of $100 million in annual revenue when it was acquired in 2001 by AON Consulting. Following the sale Mr. Salig was Executive Vice President of AON Consulting until 2004. Mr. Salig serves on the board of Robot Galaxy, a children's toy and experience company and is involved in local charitable activities. Mr. Salig began his professional career in the financial services industry serving in various Human Resources functions including recruitment & employment, compensation & benefits, and related regulatory & compliance areas. Mr. Salig is a graduate of Columbia College, and has Master's Degrees from Columbia University and New York University Graduate School of Business.
Michael T. Eustace has over 20 years of experience in the financial industry. Prior to returning to UBS in December of 2015, Mr. Eustace spent 6 years at Credit Suisse Securities USA, LLC. Previously, Mr. Eustace was a Senior Vice President with UBS Private Wealth Management from 2004 to 2009. Mr. Eustace started his career with Merrill Lynch's Private Banking and Investment Group in 1996, in Washington, DC. Mr. Eustace and his team moved to New York in 2004 in order to provide greater access to the financial markets and to better serve their international clients. During his time at Credit Suisse, Mr. Eustace worked directly with firm's Investment Bank in both Canada and the United States to provide a One Bank Solution coverage to the firm's Key Clients and to ensure complete access to all the firm's wealth management resources. Mr. Eustace specializes in advising corporate clients on managing both liquid and illiquid concentrated stock strategies in a customized manner that is aligned with their long term wealth management goals. He was responsible for building out and establishing Credit Suisse’s private banking business in Canada from January 2013 to December 2015. Mr. Eustace and his team re-joined the International Division of UBS Financial Services in December of 2015 shortly after Credit Suisse announced it would be exiting the North American Private Banking business. Mr. Eustace is a graduate of Concordia University in Montreal, Canada where he majored in U.S. and Canadian Political Science.